A new report from BioWorld examines regulatory, litigation and enforcement issues in the drug development process, along with their implications, case studies and an assessment of best practices and what-not-to-do guidance.
Laws govern the development of drugs and medical devices, and no amount of business instinct can substitute for knowledge of the law. Maneuvering through such profoundly regulated markets requires facts, not luck, and this report delivers that indispensable information.
At 500 pages, Drug & Device Litigation & Enforcement: Key Cases Driving the Future of Biotech, Pharma and Med-Tech Development cites about 200 cases. More than 40 reference tools are included, and expert guidance from industry insiders gives readers information that can make the difference in avoiding the "worst-case scenario."
For information, call (800) 688-2421 or (404) 262-5476, or go to www.BioWorld.com.